Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "CHI"

5468 News Found

PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem
Digitisation | April 23, 2026

PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem

Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing


ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer
People | April 22, 2026

ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer

Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations


Blueneem Medical Devices  appoints Manoj Tumkur Venkatachala as Chief Product Officer
People | April 22, 2026

Blueneem Medical Devices appoints Manoj Tumkur Venkatachala as Chief Product Officer

Manoj has over two decades of experience in healthcare operations and biomedical engineering


NHA convenes Chintan Shivir to accelerate Ayushman Bharat schemes
Policy | April 18, 2026

NHA convenes Chintan Shivir to accelerate Ayushman Bharat schemes

Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM


Danone India backs community-led anaemia screening for 1 lakh children in UP
Public Health | April 17, 2026

Danone India backs community-led anaemia screening for 1 lakh children in UP

The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner


Teva launches Home Ground platform to tackle isolation in schizophrenia care
Digitisation | April 16, 2026

Teva launches Home Ground platform to tackle isolation in schizophrenia care

The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping


FDA grants priority review to Daiichi Sankyo & Merck’s lung cancer drug application
Drug Approval | April 15, 2026

FDA grants priority review to Daiichi Sankyo & Merck’s lung cancer drug application

The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck


New guidance aims to speed up diagnosis of childhood abdominal cancers
News | April 14, 2026

New guidance aims to speed up diagnosis of childhood abdominal cancers

Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours


Imagene AI teams up with Daiichi Sankyo to supercharge cancer drug development
Digitisation | April 14, 2026

Imagene AI teams up with Daiichi Sankyo to supercharge cancer drug development

A major push to sharpen the future of cancer treatment is underway


FDA fast-tracks Daiichi Sankyo & Merck lung cancer drug review
Drug Approval | April 14, 2026

FDA fast-tracks Daiichi Sankyo & Merck lung cancer drug review

The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis